☰
AKI™ Global AI Intelligence Index
🛡️ Provenance 🎯 Focus Mode ✨ Subscribe Free
⚡ Superintelligence Index (Top 100) ⚖️ Intelligence Platforms 🌐 Developer Ecosystem 🧠 Live Models (218) 🔥 Viral 15 🚀 Trending Open Source 15
PASSPORT: AKI Platform · OBJECT ID: aki:ai-dividend:catalog:v2 SHA-256: c7e2b9a4...e0f2a4
ZIP-1.0 Actuarial Governance · SEC 10-K Audited Telemetry
Rank #96 · AI MedTech & Algorithmic Biosensing

DexCom, Inc. (DXCM)

DexCom, Inc. is an AI MedTech & Algorithmic Biosensing pioneer commercializing real-time continuous glucose monitoring (G7, Stelo) and automated insulin delivery (AID) algorithms. DexCom pays a 0.00% cash dividend, returning capital to shareholders via an active $750M share repurchase program (1.85% TSR Capital Return Yield).

Cash Dividend Yield
0.00%
100% Reinvested in AI Algorithms
TSR / Buyback Yield
1.85%
$750M Repurchase Authorization
FCF Safety Score
94/100
Institutional Grade Safety
Composite AKI Score
68.5
Actuarial Compounder Rank #96
← Back to Complete AI Dividend 100 Index Snapshot: 2026-10-13 · Data Sources: SEC 10-K, DexCom Investor Relations, FDA Premarket Approval AI Telemetry